Table 4.
a. By place of manufacture | ||||
Combined (imported + domestic) | Manufactured outside India | Manufactured in India | p-value | |
Human insulin | ||||
Vial |
USD 4.97 | INR 323.5 (n = 187) |
-- |
USD 4.97 | INR 323.5 (n = 187) |
|
Cartridge |
USD 12.24 | INR 796.6 (n = 9) |
USD 12.24 | INR 796.6 (n = 7) |
USD 13.55 | INR 881.6 (n = 2) |
0.0278a |
Pen |
USD 17.98 | INR 1170.0 (n = 16) |
USD 17.98 | INR 1170.0 (n = 16) |
-- -- |
|
Analogue insulins | ||||
Vial |
USD 17.96 | INR 1168.8 (n = 6) |
– |
USD 17.96 | INR 1168.8 (n = 6) |
|
Cartridge |
USD 27.56 | INR 1794.0 (n = 12) |
– |
USD 27.56 | INR 1794.0 (n = 12) |
|
Pen |
USD 33.20 | INR 2160.0 (n = 49) |
USD 32.47 | INR 2113.3 (n = 33) |
USD 42.66 | INR 2775.6 (n = 16) |
< 0.0001a |
b. By company’s origin | ||||
Combined (Non-Indian + Indian) | Non-Indian Company | Indian Company | ||
Human insulin | ||||
Vial |
USD 4.97 | INR 323.5 (n = 187) |
USD 5.15 | INR 335.2 (n = 105) |
USD 4.86 | INR 316.7 (n = 82) |
< 0.0001a |
Cartridge |
USD 12.24 | INR 796.6 (n = 9) |
USD 12.24 | INR 796.6 (n = 9) |
– | |
Pen | USD 17.98 | INR 1170.0 (n = 16) |
USD 17.98 | INR 1170.0 (n = 16) |
– | |
Analogue insulin | ||||
Vial |
USD 17.96 | INR 1168.8 (n = 6) |
– | USD 17.96 | INR 1168.8 (n = 6) | |
Cartridge |
USD 27.56 | INR 1794.0 (n = 12) |
USD 28.60 | INR 1861.3 (n = 18) |
USD 23.32 | INR 1517.6 (n = 3) | 0.0142a |
Pen |
USD 33.20 | INR 2160.0 (n = 49) |
USD 33.20 | INR 2160.0 (n = 49) |
– |
aThe difference in median prices in the groups (1. Manufactured outside (imported) versus in India (domestic), and 2. Company’s origin being non-Indian versus Indian) are statistically significant at α-significance level of 0.05 (Wilcoxon rank sum test)